Floris van Delft

Company: Synaffix

Job title: Chief Scientific Officer

Seminars:

Expansion of toxSYN Platform with Best-in-Class Linker Payloads Based on Validated Topiosomerase 1 Inhibitor (Exatecap) & DNA-damaging Agent (Calicheamicin) 4:15 pm

Demonstrating how SYNtecan E™ and SYNeamicin G™ linker-payloads show excellent in vivo efficacy and tolerability Immunogenic cell-death driven by SYNtecan E™ ADCs corroborated in syngeneic mouse models Discussing how a comprehensive set of linker-payloads enables matching of payload MOA to any clinical indicationRead more

day: day 1- pm